Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Rafaela Pirolli"'
Autor:
Rafaela Pirolli, Viviane Teixeira Loiola de Alencar, Felipe Leonardo Estati, Adriana Regina Gonçalves Ribeiro, Daniella Yumi Tsuji Honda, Mariana de Oliveira, Joao Paulo da Silveira Nogueira Lima, Elizabeth Santana dos Santos, Andrea Paiva Gadelha Guimarães, Glauco Baiocchi, Alexandre André Balieiro Anastácio da Costa
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Benefit of carboplatin and dose-dense weekly paclitaxel (ddCT) in first line treatment of ovarian cancer patients has been different in Western and Asian studies. In the present study we compare progression-free survival (PFS) of
Externí odkaz:
https://doaj.org/article/94eed9345bc54a13aa448b9619bd3b3e
Autor:
Marcos Pedro Guedes Camandaroba, Viviane Teixeira Loiola de Alencar, Vladmir Cláudio Cordeiro de Lima, Rafaela Pirolli, Camilla Albina Zanco Fogassa
Publikováno v:
Journal of Thoracic Oncology. 16:1379-1391
Introduction Brain metastases (BMs) occur in 40% of patients with lung cancer. The activity of immunotherapy in these patients, however, remains controversial, as the cornerstone treatment is radiotherapy (RT). Because RT is associated with adverse e
Autor:
Vladmir C. Cordeiro Lima, Marina de Paula Canal, Cynthia A Bueno, Marina Sonagli, Poliana de Andrade, Fernanda A Oliveira, Fabiana Baroni Alves Makdissi, Mariana P Xerfan, Sinara Figueiredo, Fernando Ab Campos, Solange Moraes Sanches, Monique Celeste Tavares, Rafaela Pirolli, Bruna Raphaeli Silva Mattos, Vinicius Fernando Calsavara, Marcelle Goldner Cesca, Camilla Albina Zanco Fogassa
Publikováno v:
Cancer Research. 80:P2-16
Introduction: Neoadjuvant chemotherapy in addition to increasing the rate of breast conservation, offers a invaluable opportunity to monitor individual tumor response which may be related to survival outcomes. In view of this, neoadjuvant treatment h
Autor:
Dayana Melamed, André Luis Ferreira Azeredo da Silva, Francisco José Veríssimo Veronese, Karolinny Borinelli de Aquino Moura, Rafaela Pirolli, Aimee Sauer, Paula Marques Prates Behrens
Publikováno v:
Clinical Kidney Journal
Background The aim of this study was to report the prevalence and mortality associated with anticoagulant-related nephropathy (ARN) through a systematic review of the literature. Methods Electronic searches were conducted in the Medline and EMBASE da
Autor:
Rafael Lima Viana, M.F. Simões, Fernando Augusto Batista Campos, Vladmir Cláudio Cordeiro de Lima, Luciana de Moura Leite, Bruna Raphaeli Silva Mattos, Paula Tavares Guimarães, Noam Pondé, Debora Maciel Santana, Daniella Dias Silva Sá, F. Rocha, Sinara Figueiredo Silva, Erick Figueiredo Saldanha, Solange Moraes Sanches, Marcelle Goldner Cesca, Rafaela Pirolli, Camilla Albina Zanco Fogassa, Monique Celeste Tavares, Simone Klog Loose
Purpose: Recently, phase I studies with novel antibody drug conjugates targeting HER2 suggested benefit in HER2-low patients – defined as immunohistochemistry(IHC) +1 or +2 FISH/ISH non-amplified, with advanced breast cancer(BC). Data on the progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98fd26dd52572004e785fb728f0e6d0
https://doi.org/10.21203/rs.3.rs-420934/v1
https://doi.org/10.21203/rs.3.rs-420934/v1
Autor:
Adriana Regina Gonçalves Ribeiro, Alexandre Andre Balieiro Anastacio da Costa, Rafaela Pirolli, Viviane Teixeira Loiola de Alencar, Glauco Baiocchi, Felipe Leonardo Estati, Maria Nirvana Formiga, Andrea Paiva Gadelha Guimarães, Giovana Tardin Torrezan, Dirce Maria Carraro
Publikováno v:
Annals of surgical oncology. 28(7)
Phase III trials evaluating the role of secondary cytoreductive surgery (SCS) in recurrent ovarian cancer have pointed to the importance of patient selection. Two studies showed conflicting results regarding the benefit of SCS in BRCA1/2 mutation car
Autor:
Éverton Melo, Tiago Felismino, Luciana Beatriz Mendes Gomes Siqueira, Juliana Rosa Chinelato, Bruno Cezar de Mendonça Uchôa, Jose Ecio Batista Rosado, Victor Hugo Fonseca de Jesus, Ana Paula Rondina Correa, Francisca Giselle Rocha Moura, Marcelle Goldner Cesca, Rafaela Pirolli, Mauro Daniel Spina Donadio
Publikováno v:
Journal of Clinical Oncology. 39:e16086-e16086
e16086 Background: The role of HER2 positive (HER2+) as a prognostic biomarker for gastric/gastroesophageal junction cancer (G-GEJC) is controversial. Recently, the HER2-low (HER2l) concept has emerged and proved to predict response to trastuzumab de
Autor:
Poliana de Andrade, Marcelle Goldner Cesca, Monique Celeste Tavares, Solange Moraes Sanches, Flores Campos, V.C.C. de Lima, Camilla Albina Zanco Fogassa, Rafaela Pirolli, Simone Klog Loose, Luciana de Moura Leite, F.A. de Oliveira, Bruna Raphaeli Silva Mattos, Sinara Figueiredo Silva
Publikováno v:
Annals of Oncology. 31:S342
Autor:
Marcelle Goldner Cesca, Vladmir Cláudio Cordeiro de Lima, Solange Moraes Sanches, Fernanda A. Oliveira, Sinara Figueiredo Silva, Fernando Augusto Batista Campos, Rafaela Pirolli, Monique Celeste Tavares, Camilla Albina Zanco Fogassa, Poliana de Andrade, Mariana Pinheiro Xerfan, Luciana de Moura Leite, Bruna Raphaeli Silva Mattos
Publikováno v:
Web of Science
e12649 Background: Discordance between immunohistochemistry (IHC) and molecular subtyping from pre and post neoadjuvant chemotherapy (NACT) biopsy specimens in breast cancer (BC) patients (pts) varies in the literature. This information could have pr
Autor:
Adriana Regina Gonçalves Ribeiro, Alexandre Andre Balieiro Anastacio da Costa, Rafaela Pirolli, Viviane Teixeira Loiola de Alencar, Mariana Romero de Oliveira, Glauco Baiocchi, Andrea Paiva Gadelha Guimarães, Felipe Leonardo Estati
Publikováno v:
Web of Science
e18059 Background: The benefit of dose dense chemotherapy (ddCT) in the adjuvant treatment of ovarian carcinoma (OC) is not clear. There is one positive Japanese trial and two negative trials in non-Asian patients, which differed from the JGOG 3016 t